TAK icon

Takeda Pharmaceutical

310 hedge funds and large institutions have $1.2B invested in Takeda Pharmaceutical in 2025 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 133 increasing their positions, 65 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
310
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26.6M
Puts
$216K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MYIA
276
Mount Yale Investment Advisors
Colorado
$1.8K
AAS
277
Ameritas Advisory Services
Nebraska
$1.7K
PWA
278
Physician Wealth Advisors
Utah
$1.67K
WTC
279
WhitTier Trust Company
Nevada
$1.62K
HPC
280
HM Payson & Co
Maine
$1.55K
EPIMS
281
Evelyn Partners Investment Management Services
$1.51K
AT
282
Arlington Trust
Alabama
$1.39K
FRA
283
Front Row Advisors
California
$1.33K
RI
284
Ridgewood Investments
New Jersey
$1.11K
GC
285
Gould Capital
Washington
$1.08K
CI
286
CX Institutional
Indiana
$1K
WA
287
WPG Advisers
Maryland
$974
BLC
288
Brown, Lisle/Cummings
Rhode Island
$897
PWAM
289
Private Wealth Asset Management
Iowa
$819
SIS
290
Sound Income Strategies
Florida
$740
FG
291
Fairman Group
Pennsylvania
$711
SL
292
Salomon & Ludwin
Virginia
$632
BA
293
Bellwether Advisors
Nebraska
$557
CA
294
Clearstead Advisors
Ohio
$387
AAG
295
Armstrong Advisory Group
Massachusetts
$387
AP
296
Atwood & Palmer
Missouri
$387
ICM
297
Islay Capital Management
Texas
$387
Kayne Anderson Rudnick Investment Management
298
Kayne Anderson Rudnick Investment Management
California
$325
AWM
299
Abound Wealth Management
Tennessee
$310
AF
300
Advisornet Financial
Minnesota
$309